Skip to main content
OpenTrials

Clinical trial condition

Tetanus

Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.

220 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Tetanus trial results

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Novara, Piedmont, Italy
  • GSK Investigational Site Cagliari, Sardinia, Italy
View Trial Details
Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

NCT01738477

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Fullerton, California, United States
View all 20 locations
View Trial Details
Completed

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

NCT01287949

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD investigational site Clermont-Ferrand, France
  • Sanofi Pasteur MSD investigational site Lille, France
  • Sanofi Pasteur MSD investigational site Montpellier, France
  • Sanofi Pasteur MSD investigational site Paris, France
View Trial Details
Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

NCT01546909

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations
  • SPMSD Investigational Site 120 Angers, France
  • SPMSD Investigational Site 103 Arras, France
  • SPMSD Investigational Site 155 Asnières, France
  • SPMSD Investigational Site 125 Bersée, France
View all 45 locations
View Trial Details
Completed

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

NCT01249183

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD Investigational Site Angers, France
  • Sanofi Pasteur MSD Investigational Site Châtellerault, France
  • Sanofi Pasteur MSD Investigational Site Clermont-Ferrand, France
  • Sanofi Pasteur MSD Investigational Site Gières, France
View all 20 locations
View Trial Details

Related conditions